Share on StockTwits
 

Illumina (NASDAQ:ILMN) set a new 52-week high during trading on Friday, Analyst RN reports. The stock traded as high as $157.00 and last traded at $155.89, with a volume of 1,019,137 shares. The stock had previously closed at $150.06.

A number of analysts have recently weighed in on ILMN shares. Analysts at Leerink Swann set a $160.00 price target on shares of Illumina in a research note to investors on Wednesday, January 29th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $150.00 to $175.00 in a research note to investors on Wednesday, January 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note to investors on Wednesday, January 29th. They now have a “neutral” rating on the stock. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $117.24.

In other Illumina news, CFO Marc Stapley unloaded 20,038 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $151.32, for a total transaction of $3,032,150.16. Following the transaction, the chief financial officer now directly owns 21,797 shares in the company, valued at approximately $3,298,322. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Illumina has a 52-week low of $48.00 and a 52-week high of $154.99. The stock has a 50-day moving average of $126.4 and a 200-day moving average of $95.85. The company has a market cap of $19.881 billion and a P/E ratio of 166.73.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter last year, the company posted $0.42 earnings per share. Illumina’s revenue was up 25.1% compared to the same quarter last year. Analysts expect that Illumina will post $2.06 EPS for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.